Search research articles
Contact Us
Filters
Showing results (51-60 of 132) with videos related to
Page
of 14
Sort By:
Gastrointestinal Cancer Research : GCR
|
March 5, 2009
Optimizing imatinib mesylate treatment in gastrointestinal stromal tumors
Yixing Jiang, Lee Ming, Alberto J Montero, et al.
The Journal of Surgical Research
|
January 19, 2023
Adjuvant Therapy in Breast Cancer Patients With Microscopic Residual Disease
Lifen Cao, Robert Shenk, Nickolas Stabellini, et al.
Cancer
|
April 1, 2022
A comparison of local therapy alone with local plus systemic therapy for stage I pT1aN0M0 HER2+ breast cancer: A National Cancer Database analysis
Lifen Cao, Christopher W Towe, Robert Shenk, et al.
Frontiers in Oncology
|
May 11, 2023
Adjuvant chemotherapy is associated with an overall survival benefit regardless of age in ER+/HER2- breast cancer pts with 1-3 positive nodes and oncotype DX recurrence score 20 to 25: an NCDB analysis
Nickolas Stabellini, Lifen Cao, Christopher W Towe, et al.
Current Problems in Cancer
|
July 10, 2026
Genomic risk distribution, adjuvant chemotherapy trends, and survival outcomes in women with pT1, grade 1-2, ER/PR-positive, LVI-negative breast cancer
Nickolas Stabellini, Maya Lubarsky, Ananya Munjal, et al.
Breast Cancer Research and Treatment
|
October 16, 2021
Adjuvant trastuzumab with or without chemotherapy in stage 1 pT1N0 HER2+ breast cancer: a National Cancer Database analysis
Lifen Cao, Robert Shenk, Nickolas Stabellini, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|
May 18, 2019
Debating the Optimal Approach to Nodal Management After Pathologic Complete Response to Neoadjuvant Chemotherapy in Patients With Breast Cancer
Stacey Carter, Heather Neuman, Eleftherios P Mamounas, et al.
Journal of Gastrointestinal Oncology
|
July 20, 2012
Patient with synchronous low grade leiomyosarcoma of the thigh, primary pancreatic neuroendocrine tumor, and lung metastases: Why biopsy of metastases should be the standard
Jesus Fabregas, Tony N Talebi, Caio Rocha Lima, et al.
Current Medical Research and Opinion
|
November 8, 2016
Comparison of health utility weights among elderly patients receiving breast-conserving surgery plus hormonal therapy with or without radiotherapy
Askal Ayalew Ali, Hong Xiao, Rima Tawk, et al.
Breast Cancer Research and Treatment
|
July 12, 2014
Cost-effectiveness analysis of everolimus plus exemestane versus exemestane alone for treatment of hormone receptor positive metastatic breast cancer
Vakaramoko Diaby, Georges Adunlin, Simon B Zeichner, et al.
Page
of 14
Search research articles
Search
Showing results (51-60 of 132) with videos related to
Sort By:
Page
of 14
Gastrointestinal Cancer Research : GCR
|
March 5, 2009
Optimizing imatinib mesylate treatment in gastrointestinal stromal tumors
Yixing Jiang, Lee Ming, Alberto J Montero, et al.
The Journal of Surgical Research
|
January 19, 2023
Adjuvant Therapy in Breast Cancer Patients With Microscopic Residual Disease
Lifen Cao, Robert Shenk, Nickolas Stabellini, et al.
Cancer
|
April 1, 2022
A comparison of local therapy alone with local plus systemic therapy for stage I pT1aN0M0 HER2+ breast cancer: A National Cancer Database analysis
Lifen Cao, Christopher W Towe, Robert Shenk, et al.
Frontiers in Oncology
|
May 11, 2023
Adjuvant chemotherapy is associated with an overall survival benefit regardless of age in ER+/HER2- breast cancer pts with 1-3 positive nodes and oncotype DX recurrence score 20 to 25: an NCDB analysis
Nickolas Stabellini, Lifen Cao, Christopher W Towe, et al.
Current Problems in Cancer
|
July 10, 2026
Genomic risk distribution, adjuvant chemotherapy trends, and survival outcomes in women with pT1, grade 1-2, ER/PR-positive, LVI-negative breast cancer
Nickolas Stabellini, Maya Lubarsky, Ananya Munjal, et al.
Breast Cancer Research and Treatment
|
October 16, 2021
Adjuvant trastuzumab with or without chemotherapy in stage 1 pT1N0 HER2+ breast cancer: a National Cancer Database analysis
Lifen Cao, Robert Shenk, Nickolas Stabellini, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|
May 18, 2019
Debating the Optimal Approach to Nodal Management After Pathologic Complete Response to Neoadjuvant Chemotherapy in Patients With Breast Cancer
Stacey Carter, Heather Neuman, Eleftherios P Mamounas, et al.
Journal of Gastrointestinal Oncology
|
July 20, 2012
Patient with synchronous low grade leiomyosarcoma of the thigh, primary pancreatic neuroendocrine tumor, and lung metastases: Why biopsy of metastases should be the standard
Jesus Fabregas, Tony N Talebi, Caio Rocha Lima, et al.
Current Medical Research and Opinion
|
November 8, 2016
Comparison of health utility weights among elderly patients receiving breast-conserving surgery plus hormonal therapy with or without radiotherapy
Askal Ayalew Ali, Hong Xiao, Rima Tawk, et al.
Breast Cancer Research and Treatment
|
July 12, 2014
Cost-effectiveness analysis of everolimus plus exemestane versus exemestane alone for treatment of hormone receptor positive metastatic breast cancer
Vakaramoko Diaby, Georges Adunlin, Simon B Zeichner, et al.
Page
of 14